Meeting Expectations: US FDA Communications Getting High Marks – Before COVID, At Least
Executive Summary
FDA’s interactions with sponsors to support drug development activities are generally timely and effective – but industry still sees room for improvement in assuring ‘best practices’ are followed across all divisions.